Clinical trial of a monophasic estroprogestin oral formulation containing 20 μg ethinyl estradiol and 75 μg gestodene

Author： Lello S.   Monterubbianesi M.   Guardianelli F.   Bianchi C.   Simonelli C.  

Publisher： Informa Healthcare

ISSN： 1473-0766

Source： Gynecological Endocrinology, Vol.15, Iss.4, 2001-08, pp. : 265-271

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Effect of a combined oral contraceptive containing 20 μg ethinyl estradiol and 75 μg gestodene on hemostatic parameters

By Aldrighi José   Carneiro De Campos Luis   Eluf Gebara Otávio   Petta Carlos   Bahamondes Luis  

Gynecological Endocrinology, Vol. 22, Iss. 1, 2006-01 ,pp. : 1-4

Informa Healthcare

Access to resources Recommend Favorite

Effects on body weight and body composition of a low-dose oral estroprogestin containing ethinyl estradiol 20 μg plus levonorgestrel 100 μg

By Lello Stefano   Vittori Giorgio   Paoletti Anna Maria   Sorge Roberto   Guardianelli Francesca   Melis Gian Benedetto  

Gynecological Endocrinology, Vol. 23, Iss. 11, 2007-11 ,pp. : 632-637

Informa Healthcare

Access to resources Recommend Favorite

Increased plasma viscosity in young women with polycystic ovary syndrome using an oral contraceptive containing 35 μg ethinyl estradiol and 2 mg cyproterone acetate

By Markantes George   Saltamavros Alexandros D.   Vervita Vasiliki   Armeni Anastasia K.   Karela Anastasia   Adonakis George   Decavalas George   Georgopoulos Neoklis A.  

Gynecological Endocrinology, Vol. 27, Iss. 12, 2011-12 ,pp. : 971-977

Informa Healthcare

Access to resources Recommend Favorite

Triggering ovulation with 250 μg or 500 μg of r-hCG in oocyte donors treated with antagonist protocol has no effect on the number of mature oocytes retrieved: a randomized clinical trial

By Clua Elisabet   Martínez Francisca   Tur Rosa   Sanmartín Paula   Chueca Ana   Barri Pere N.  

Gynecological Endocrinology, Vol. 28, Iss. 9, 2012-09 ,pp. : 678-681

Informa Healthcare

Access to resources Recommend Favorite

Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 µg ethinyl estradiol and 3 mg drospirenone

By Milsom I.   Lete I.   Bjertnaes A.   Rokstad K.   Lindh I.   Gruber C.J.   Birkhäuser M.H.   Aubeny E.   Knudsen T.   Bastianelli C.  

Human Reproduction, Vol. 21, Iss. 9, 2006-09 ,pp. : 2304-2311

Oxford University Press

Access to resources Recommend Favorite